Industry Provider Profiles
SNBL Clinical Pharmacology Center, Inc.

• Company Overview & History
• Services
• Features
• Leadership
• Contact Company

Company Overview & History

SNBL CPC, Inc. is a 96-bed, state of the art, Phase I/IIa Clinical Pharmacology Center focused on supporting complex, multi-faceted, early stage Clinical Development programs. We manage complexity by employing the best-in-class facility, technology and operational excellence necessary to ensure the integrity of each trial. We partner with pharmaceutical companies to accelerate product development and to help expedite marketability.

SNBL was founded in 1957 as Japan's first contract research organization (CRO). It immediately gained recognition for its preclinical research. SNBL, now recognized as Japan's foremost CRO and worlds leading nonhuman primate (NHP) research organization, has evolved into an international full-service CRO with facilities, offices and subsidiaries in the U.S., Europe, and China.

Services

Core Competency

Design, Conduct Phase I/IIa Clinical Trials

• First-in-human
• Dose Escalation
• Bioavailability/Bioequivalence
• PK/PD
• Food Effect
• QT/QTc
• Vaccine Development
• Radiolabel - Mass Balance

Secondary (through other SNBL Group companies)

• Pharmacokinetic/Pharmacodynamic Analysis
• Pharmacokinetics and Bioanalysis Center (Wakayama, Japan)
• Central Cardiology lab capabilities
• Data Management/Statistical Analysis

Features

96 bed Inpatient facility

48 beds with Intensive Care-level bedside monitoring

40 VS1 machines

• Blood Pressure
• Temperature
• Pulse
• Pulse Oximetry

Phillips ECG (12 Lead) machines
ECG Telemetry Transmitters
Phillips Heart Monitors
B Braun Intravenous Pumps
Bedside Oxygen
Crash Cart/Defibrillator

Separate Outpatient Facility

5 Examination Rooms
2 Phlebotomy Rooms

Technology

Initiator Clinical Information System
ECG Digital Management System
QTc Measurement and Analysis Software
Access Control (Security)
Comprehensive Environmental Monitoring

Leadership

Mohamed S. Al-Ibrahim, M.D., FACP - CMO and President

Board Certification:

• Internal Medicine
• Infectious Diseases

Executive Positions:

• Chief Medical Officer, Maryland General Hospital, Baltimore
• Executive Chief of Staff, VA Maryland Health Care System
• Professor of Medicine & Associate Dean, University of Maryland, School of Medicine

Military Service:

• Colonel, Medical Corps, USAR

Major Research Interests:

• Adult Vaccine Development (Pneumococcal, Influenza, Pertussis)
• Antibiotic Development Trials (Cefuroxime, Sparfloxacin, Levofloxacin, Clinafloxacin)

Masaru Kaneko, M.D. - Medical Director

Board Certification:

• American Board of Psychiatry and Neurology
• Japanese Society of Neurology
• Japanese Society of Internal Medicine

Executive Positions:

• Vice-Director, Matsudo Neurology Clinic, Japan

Clinical Positions:

• Staff Neurologist, Chiba University Hospital, Japan
• Staff Neurologist, Nakaizu Rehabilitation center, Japan

Major Research Interests:

• Neuropathy
• Epilepsy
• Neuromuscular Diseases
• Aphasia

If you are interested in contacting this company, please complete and submit the form below. A representative from the company will follow up with you.